TARDBP and amyotrophic lateral sclerosis: Further characterization of the L-BMAA effect on TDP43 proteinopathy involved biochemical fractionation, highlighting a significant increase in insoluble TDP-43, a well-known marker of ALS (Figures 4C, D).